Results 121 to 130 of about 138,752 (279)
There is increasing evidence that long-term peritoneal dialysis (PD) is associated with structural changes in the peritoneal membrane. Inhibition of the renin-angiotensin system has been demonstrated to lessen peritoneal injury and to slow the decline in
Ozturk, Savaş +9 more
core
Objective The aim of this study was to evaluate the sensitivity of the 2023 American College of Rheumatology (ACR)/EULAR classification criteria for antiphospholipid syndrome (APS) in a real‐world cohort of women diagnosed with primary obstetric APS (oAPS) and to assess their ability to identify patients at risk of future pregnancy complications ...
Francesca Ruffilli +10 more
wiley +1 more source
[Maintaining residual renal function in patients on dialysis].
There are evidences supporting a positive impact of renal residual function (RRF) on survival and quality of life of dialysis patients. Many strategies are available in clinical practices to maintain RRF.
Ryckelynck, Jean-Philippe +2 more
core +1 more source
Dialysis Adequacy and Residual Renal Function [PDF]
+5 more sources
Background and purpose Recanalisation of renal artery bridging stent graft thrombosis in patients with delayed ischemia lasting more than 24 h could potentially save some residual renal function.
Stevo Duvnjak +3 more
doaj +1 more source
Objective This research article aims to describe the prevalence, associations, and health‐related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analyzed (2013–2021).
Amanda M. Saracino +42 more
wiley +1 more source
Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial
Background: The ability of urinary biomarkers to predict residual renal function (RRF) decline in peritoneal dialysis (PD) patients has not been defined.
Clarke, Margaret +10 more
core +1 more source
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy in systemic lupus erythematosus (SLE), but the weight‐based dosing does not account for clinical factors that can introduce individual variability in drug metabolism and clearance. We leveraged longitudinal data from a prospective SLE cohort to identify clinical factors that predict ...
Jay J. Patel +6 more
wiley +1 more source
Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose
Background and Methods. The importance of residual renal function is well recognized in peritoneal dialysis but its role in haemodialysis (HD) has received much less attention.
Wellsted, D. +4 more
core
Background/Objectives: This prospective study aimed to assess residual cortical function at follow-up in patients with traumatic renal injuries using Tc-99m dimercaptosuccinic acid (DMSA) single-photon emission computed tomography (SPECT) and evaluate ...
Chan Park +3 more
core +1 more source

